Access to Iplex for Patients with ALS

July 27, 2009

Insmed Inc, today announced that, effective immediately, the Company will cease the supply of Iplex to any new patients. In addition, the Company will not initiate further clinical trials with Iplex at this time. The Company has determined that its limited inventory on hand must be conserved for the treatment of existing patients.

Statement from Insmed

Page Last Updated: 07/15/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English